[go: up one dir, main page]

PL354653A1 - Zastosowanie tlenku azotu do leczenia zwężenia dróg oddechowych - Google Patents

Zastosowanie tlenku azotu do leczenia zwężenia dróg oddechowych

Info

Publication number
PL354653A1
PL354653A1 PL00354653A PL35465300A PL354653A1 PL 354653 A1 PL354653 A1 PL 354653A1 PL 00354653 A PL00354653 A PL 00354653A PL 35465300 A PL35465300 A PL 35465300A PL 354653 A1 PL354653 A1 PL 354653A1
Authority
PL
Poland
Prior art keywords
treatment
nitric oxide
airway constriction
constriction
airway
Prior art date
Application number
PL00354653A
Other languages
English (en)
Inventor
Josephine Hjoberg
Goran Hedenstierna
Marieann Hogman
Original Assignee
Aga Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aga Ab filed Critical Aga Ab
Publication of PL354653A1 publication Critical patent/PL354653A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL00354653A 1999-11-03 2000-11-02 Zastosowanie tlenku azotu do leczenia zwężenia dróg oddechowych PL354653A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903985A SE9903985D0 (sv) 1999-11-03 1999-11-03 Use of nitric oxide
PCT/SE2000/002153 WO2001032202A1 (en) 1999-11-03 2000-11-02 Use of nitric oxide for the treatment of airway constriction

Publications (1)

Publication Number Publication Date
PL354653A1 true PL354653A1 (pl) 2004-02-09

Family

ID=20417596

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00354653A PL354653A1 (pl) 1999-11-03 2000-11-02 Zastosowanie tlenku azotu do leczenia zwężenia dróg oddechowych

Country Status (20)

Country Link
EP (1) EP1225913B8 (pl)
JP (1) JP2003513048A (pl)
CN (1) CN1230199C (pl)
AR (1) AR026335A1 (pl)
AT (1) ATE302023T1 (pl)
AU (1) AU778347B2 (pl)
BR (1) BR0015329A (pl)
CA (1) CA2389655A1 (pl)
CZ (1) CZ20021559A3 (pl)
DE (1) DE60022070T2 (pl)
EE (1) EE200200240A (pl)
ES (1) ES2248153T3 (pl)
HU (1) HUP0203065A3 (pl)
IL (1) IL149170A0 (pl)
MX (1) MXPA02004069A (pl)
NO (1) NO20022113L (pl)
PL (1) PL354653A1 (pl)
SE (1) SE9903985D0 (pl)
WO (1) WO2001032202A1 (pl)
ZA (1) ZA200203391B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9801398D0 (en) 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds
US6601580B1 (en) * 2000-06-28 2003-08-05 The General Hospital Corporation Enhancing therapeutic effectiveness of nitric oxide inhalation
ATE310514T1 (de) 2002-04-19 2005-12-15 Yissum Res Dev Co Beta-agonisten-verbindungen mit stickoxid- donatoren-gruppen und reaktionsfähige sauerstoffspezies-fängergruppen und ihre verwendung bei der behandlung von atemwegsstörungen
RS110504A (en) * 2002-06-21 2007-02-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education, Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
KR20110094321A (ko) * 2008-12-03 2011-08-23 가부시키가이샤 엘티티 바이오파마 수식형 수퍼옥사이드 디스뮤타아제 함유 흡입제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992010228A1 (en) * 1990-12-05 1992-06-25 The General Hospital Corporation Devices for treating pulmonary vasoconstriction and asthma
US5747026A (en) * 1993-10-15 1998-05-05 University Of Alabama At Birmingham Research Foundation Antioxidants
AU6031096A (en) * 1995-06-05 1996-12-24 Duke University Nitrosylated and nitrated superoxide oxidants and reductants
GB9801398D0 (en) * 1998-01-22 1998-03-18 Anggard Erik E Chemical compounds

Also Published As

Publication number Publication date
AU778347B2 (en) 2004-12-02
DE60022070T2 (de) 2006-03-30
AR026335A1 (es) 2003-02-05
SE9903985D0 (sv) 1999-11-03
EE200200240A (et) 2003-06-16
CZ20021559A3 (cs) 2003-05-14
EP1225913A1 (en) 2002-07-31
JP2003513048A (ja) 2003-04-08
MXPA02004069A (es) 2003-08-20
NO20022113D0 (no) 2002-05-02
ATE302023T1 (de) 2005-09-15
EP1225913B8 (en) 2005-10-19
WO2001032202A1 (en) 2001-05-10
CN1230199C (zh) 2005-12-07
BR0015329A (pt) 2002-07-09
DE60022070D1 (de) 2005-09-22
AU1745601A (en) 2001-05-14
HUP0203065A3 (en) 2006-07-28
ES2248153T3 (es) 2006-03-16
EP1225913B1 (en) 2005-08-17
ZA200203391B (en) 2002-12-20
IL149170A0 (en) 2002-11-10
HUP0203065A2 (hu) 2003-01-28
CN1387441A (zh) 2002-12-25
CA2389655A1 (en) 2001-05-10
NO20022113L (no) 2002-05-02

Similar Documents

Publication Publication Date Title
HK1097437A1 (en) Therapeutic use of nitric oxide precursor
AU8015600A (en) Respiratory nitric oxide meter
IL196301A0 (en) Medicament for the treatment of hapatitis c
HK1045125B (zh) 一氧化二氮的分解方法
GB9915414D0 (en) Medical use
GB0109414D0 (en) Well treatment fluids and methods for the use thereof
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
EP1207811A4 (en) STAIN OXIDE RELEASE MEDICAL ARTICLES
IL155968A0 (en) Inhalation of nitric oxide
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0202150A2 (en) Use of nitric oxide donors for inducing neurogenesis
GB2414183B (en) Delivery of nitric oxide for therapeutic treatment
GB0004531D0 (en) The treatment of respiratory diseases
AU2003298551A8 (en) Nitric oxide and its biomedical significance
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB9907965D0 (en) Medical use
HUP0203065A3 (en) Use of nitric oxide for the treatment of airway constriction
IL144115A0 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
GB9922710D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatatives for the treatment of multiple sclerosis
GB9925379D0 (en) Medical use
HK1070561A1 (en) Use of specific dose of fandaparinux sodium for the treatment of acs
PL350128A1 (en) Use of 3-isoxazolidinones and hydroxylamine acids for the treatment of infections
HUP0300313A3 (en) Compound, pharmaceutical composition containing it and its use for the treatment of pain
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)